82 FR 32705 - Proposed Data Collection Submitted for Public Comment and Recommendations
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 82, Issue 135 (July 17, 2017)
Centers for Disease Control and Prevention
Federal Register Volume 82, Issue 135 (July 17, 2017)
| Page Range | 32705-32707 | |
| FR Document | 2017-14915 |
[Federal Register Volume 82, Number 135 (Monday, July 17, 2017)] [Notices] [Pages 32705-32707] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-14915] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day-17-1054; Docket No. CDC-2017-0055] Proposed Data Collection Submitted for Public Comment and Recommendations AGENCY: Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. ----------------------------------------------------------------------- SUMMARY: The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection entitled ``Drug Overdose Response Investigation (DORI) Data Collections.'' CDC will use the information collected to respond to urgent requests from state and local health authorities to provide epidemiological information that allows [[Page 32706]] for the selection of interventions to curb local epidemics of drug overdose. DATES: Written comments must be received on or before September 15, 2017. ADDRESSES: You may submit comments, identified by Docket No. CDC-2017- 0055 by any of the following methods:Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. Mail: Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. All relevant comments received will be posted without change to Regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to Regulations.gov. Please note: All public comment should be submitted through the Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected]. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) estimates of capital or start- up costs and costs of operation, maintenance, and purchase of services to provide information. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information, to search data sources, to complete and review the collection of information; and to transmit or otherwise disclose the information. Proposed Project Drug Overdose Response Investigation (DORI) Data Collections (OMB control number 0920-1054, Expiration 03/31/218)--Extension--National Center for Injury Prevention and Control (NCIPC), Centers for Disease Control and Prevention (CDC). Background and Brief Description In 2015, CDC received OMB approval (OMB control number 0920-1054) for a new OMB generic clearance for a three-year period to collect information to respond to urgent requests from state and local health authorities to provide epidemiological information that allows for the selection of interventions to curb local epidemics of drug overdose. CDC seeks OMB approval for an extension of this generic plan for another three-year period. Drug Overdose Response Investigation (DORI) are to be conducted in response to urgent requests from state and local health authorities to provide epidemiological information that allows for the selection of interventions to curb local epidemics of drug overdose. Of particular interest is response to increasing trends in, or changing characteristics of, overdose from prescription drugs (with a special interest in opioid analgesics such as oxycodone or methadone; benzodiazepines such as alprazolam) and/or illicit drugs (e.g., heroin). CDC's National Center for Injury Prevention and Control (NCIPC) is frequently called upon to conduct DORIs at the request of state or local health authorities seeking support to respond to urgent public health problems resulting from drug use, misuse, abuse, and overdose. Such requests are typically, but not always, made through CDC's Epi-Aid mechanism; in most investigations, CDC's epidemiological response entails rapid and flexible collection of data that evolves during the investigation period. Generic clearance is requested to ensure that timely information is collected during a DORI, which allows NCIPC to maintain critical mission function by working with state and local health authorities to protect the public's health. During an unanticipated rise in nonfatal or fatal drug overdose where the substances responsible for the health event need to be identified, drivers and risk factors are undetermined, and/or subgroups at risk need to be identified, immediate action by CDC is necessary to minimize or prevent public harm. CDC must have the ability to rapidly deploy data collection tools to understand the scope of the problem and determine appropriate action. Procedures for each investigation, including specific data collection plans, depend on the time and resources available, number of persons involved, and other circumstances unique to the urgent conditions at hand. Data are collected by epidemiologists, psychologists, medical professionals, subject matter experts, and biostatisticians. Data collected during a DORI are used to understand sudden increases in drug use and misuse associated with fatal and nonfatal overdoses, understand the drivers and risk factors associated with those trends, and identify the groups most affected. This allows CDC to effectively advise states on actions that could be taken to control the local epidemic. During a DORI, data are collected once, with the rare need for follow-up. There are no costs to respondents other than their time. [[Page 32707]] Estimated Annualized Burden Hours ---------------------------------------------------------------------------------------------------------------- Number of Average burden Type of respondent Form name Number of responses per per response Total burden respondents respondent (in hours) hours ---------------------------------------------------------------------------------------------------------------- Drug Overdose Response Drug Overdose 2,700 1 30/60 1,350 Investigation Participants. Response Investigation Data Collection Instruments. --------------------------------------------------------------- Total..................... ................ .............. .............. .............. 1350 ---------------------------------------------------------------------------------------------------------------- Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2017-14915 Filed 7-14-17; 8:45 am] BILLING CODE 4163-18-P
![Federal Register / Vol. 82, No. 135 / Monday, July 17, 2017 / Notices 32705
Background and Brief Description crisis, the federal government has The intended use of the resulting data
Overdose deaths involving recently allocated funding to improve is to increase CDC and SAMHSA
prescription opioids and heroin have access to treatment for opioid use understanding of the scope and impact
reached epidemic levels in the U.S. and disorders, reduce opioid related deaths, of the program on overdose fatalities
continue to rise. To address the and strengthen drug misuse prevention and how program effectiveness may
prescription drug/opioid overdose efforts. One program resulting from the vary among different sub-populations
crisis, the federal government has federal government’s efforts to address and settings, and to increase knowledge
recently allocated funding to improve the opioid crisis is, the Substance Abuse of barriers and facilitators to program
access to treatment for opioid use and Mental Health Services Agency implementation. Key informant
disorders, reduce opioid related deaths, (SAMHSA) Grants to Prevent interviews and focus groups with
and strengthen drug misuse prevention Prescription Drug/Opioid Overdose- participants in the activities enacted by
efforts. One program resulting from the Related Deaths (PDO/naloxone grant). the twelve state grant recipients will be
federal government’s efforts to address Through this program, SAMHSA methodology used. This will include
the opioid crisis is, the Substance Abuse awarded funding to 12 states. The state administrators of the grant and
and Mental Health Services Agency funding is aimed at reducing the other PDO/Naloxone stakeholders
(SAMHSA) Grants to Prevent number of prescription drug/opioid including advisory council members,
Prescription Drug/Opioid Overdose- overdose-related deaths and adverse first responders, social service
Related Deaths (PDO/naloxone grant). events among individuals 18 years of
providers, laypersons including end
This collection will be to evaluate the age and older through educating and
users and their family and friend. All
Substance Abuse and Mental Health training first responders and other key
focus groups and interviews will be
Services Agency (SAMHSA) Grants to community sectors on the prevention of
prescription drug/opioid overdose- analyzed through qualitative content
Prevent Prescription Drug/Opioid
related deaths, including the purchase analysis, including utilization of a
Overdose-Related Deaths.
This evaluation will seek to describe and distribution of naloxone. SAMHSA systematic coding scheme.
and understand the scope and impact of is funding the grant and CDC is Total burden in hours for this
the program on overdose. To address the responsible for conducting the grantee collection is 381. There are no costs to
prescription drug/opioid overdose evaluation. respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Number of burden per Total burden
Type of respondents Form name responses per
respondents response (in hours)
respondent (in hours)
PDO/Naloxone Advisory Committee Focus Group Discussion Guide ....... 140 1 1.5 210
Members and Grantees.
PDO/Naloxone Grantees .................. Individual Interview Discussion 36 1 1 36
Guide for Grantees.
PDO/Naloxone Stakeholders and Individual Interview Discussion 84 1 1 84
Partners. Guide for Partners.
PDO/Naloxone Laypersons .............. Individual Interview Discussion 24 1 1 24
Guide for Laypersons.
All participants (PDO Naloxone Recruitment contact script ............... 284 1 5/60 24
grantees, advisory committee,
stakeholders and partners,
laypersons).
PDO/Naloxone Grantees .................. Key Informant Selection Tool ........... 12 1 15/60 3
Total ........................................... ........................................................... ........................ ........................ ........................ 381
Leroy A. Richardson, DEPARTMENT OF HEALTH AND its continuing efforts to reduce public
Chief, Information Collection Review Office, HUMAN SERVICES burden and maximize the utility of
Office of Scientific Integrity, Office of the government information, invites the
Associate Director for Science, Office of the Centers for Disease Control and general public and other Federal
Director, Centers for Disease Control and Prevention agencies to take this opportunity to
Prevention. comment on proposed and/or
[60Day–17–1054; Docket No. CDC–2017–
[FR Doc. 2017–14914 Filed 7–14–17; 8:45 am] 0055] continuing information collections, as
BILLING CODE 4163–18–P required by the Paperwork Reduction
Proposed Data Collection Submitted Act of 1995. This notice invites
for Public Comment and comment on a proposed information
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Recommendations collection entitled ‘‘Drug Overdose
AGENCY: Centers for Disease Control and Response Investigation (DORI) Data
Prevention (CDC), Department of Health Collections.’’ CDC will use the
and Human Services (HHS). information collected to respond to
ACTION: Notice with comment period. urgent requests from state and local
health authorities to provide
SUMMARY: The Centers for Disease epidemiological information that allows
Control and Prevention (CDC), as part of
VerDate Sep<11>2014 17:45 Jul 14, 2017 Jkt 241001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\17JYN1.SGM 17JYN1](https://thefederalregister.org/doc/82_FR_32840/page/1.svg)
Document Created: 2017-07-15 03:45:49
Document Modified: 2017-07-15 03:45:49
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice with comment period. | |
| Dates | Written comments must be received on or before September 15, 2017. | |
| Contact | To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected] | |
| FR Citation | 82 FR 32705 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR